T2* from a Research Tool to a Prognostic Determinant

21.05.2009

T2* from a Research Tool to a Prognostic Determinant

Dudley J. Pennell
Royal Brompton & Harefield Hospital (London, UK)
Satellite Symposium on Thalassemia at EuroCMR 2009 in Athens, Greece

* The product/feature mentioned herein is not commercially available. Due to regulatory reasons its future availability cannot be guaranteed.